The urokinase receptor takes control of cell migration by recruiting integrins and FPR1 on the cell surface

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Gorrasi, Anna ^a   Santi, Anna Li ^a   Amodio, Giuseppina ^a   Alfano, Daniela ^a,c   Remondelli, Paolo ^a   Montuori, Nunzia ^b   Ragno, Pia ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLPEPTIDE RECEPTOR LIKE 1; FORMYLPEPTIDE RECEPTOR LIKE 2; INTEGRIN; POLYCLONAL ANTIBODY; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR; VITRONECTIN;

ARTICLE; CELL MEMBRANE; CELL MIGRATION; CELL STRAIN HEK293; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

ANTIGENS, CD29; CELL LINE; CELL MEMBRANE; CELL MOVEMENT; HEK293 CELLS; HUMANS; LIGANDS; OLIGOPEPTIDES; RECEPTORS, CELL SURFACE; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SIGNAL TRANSDUCTION;

EID: 84899818437     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086352     Document Type: Article

References (40)

1. Ridley AJ (2011) Life at the leading edge. Cell 145(7), 1012-22.
2. Montuori N, Ragno P (2009) Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR. Front Biosci 14: 2494-503.
3. Montuori N, Selleri C, Ragno P (2012) The urokinase-receptor in infectious diseases. Infez Med 20 (2): 13-8.
4. Kjaergaard M, Hansen LV, Jacobsen B, Gardsvoll H, Ploug M (2008) Structure and ligand interactions of the urokinase receptor (uPAR). Front Biosci 13: 5441-61.
5. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, et al. (1994) Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269: 32380-8.
6. Smith HW, Marshall CJ (2010) Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 11: 23-36.
7. Tang CH, Wei Y (2008) The urokinase receptor and integrins in cancer progression. Cell Mol Life Sci 65(12): 1916-32.
8. Ragno P (2006) The urokinase receptor: a ligand or a receptor? Story of a sociable molecule. Cell Mol Life Sci 63: 1028-37.
9. Montuori N, Visconte V, Rossi G, Ragno P (2005) Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules? Thromb Haemost 93(2): 192-8. (Pubitemid 40253721)
10. Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, et al. (2002) The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci USA 9: 1359-64. (Pubitemid 34136498)
11. Li Y, Ye D (2013) Molecular biology for formyl peptide receptors in human diseases. J Mol Med (Berl) 91(7):781-9.
12. Høyer-Hansen G, Pessara U, Holm A, Pass J, Weidle U, et al. (2001) Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor. Biochem J 358: 673-9. (Pubitemid 32896955)
13. Bohuslav J, Horejsí V, Hansmann C, Stöckl J, Weidle UH, et al. (1995) Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 181: 1381-90.
14. Eden G, Archinti M, Furlan F, Murphy R, Degryse B (2011) The urokinase receptor interactome. Curr Pharm Des 17: 1874-89.
15. Montuori N, Bifulco K, Carriero MV, La Penna C, Visconte V, et al. (2011) The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor. Cell Mol Life Sci 68: 2453-67.
16. Furlan F, Orlando S, Laudanna C, Resnati M, Basso V, et al. (2004) The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion. J Cell Sci 117: 2909-16. (Pubitemid 39117666)
17. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, et al. (1996) Regulation of integrin function by the urokinase receptor. Science 273(5281): 1551-5. (Pubitemid 26301666)
18. Montuori N, Carriero MV, Salzano S, Rossi G, Ragno P (2002) The cleavage of the urokinase receptor regulates its multiple functions. J Biol Chem 277: 46932-9. (Pubitemid 36159197)
19. Caiolfa VR, Zamai M, Malengo G, Andolfo A, Madsen CD, et al. (2007) Monomer dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies. J Cell Biol 179(5): 1067-82. (Pubitemid 350223499)
20. Gyetko MR, Todd RF 3rd, Wilkinson CC, Sitrin RG (1994) The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 93(4): 1380-7. (Pubitemid 24116372)
21. Bifulco K, Longanesi-Cattani I, Franco P, Pavone V, Mugione P, et al. (2012) Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion. PLoS One 7(9): e44806.
22. Montuori N, Cosimato V, Rinaldi L, Rea VE, Alfano D, et al. (2013) uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors. Thromb Haemost 109(2): 309-18.
23. Le Y, Murphy PM, Wang JM (2002) Formyl-peptide receptors revisited. Trends Immunol 23: 541-548. (Pubitemid 35223553)
24. Fazioli F, Resnati M, Sidenius N, Higashimoto Y, Appella E, et al. (1997) A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J 16: 7279-86. (Pubitemid 28010488)
25. Alfano D, Ragno P, Stoppelli MP, Ridley AJ (2012) RhoB regulates uPAR signalling. J Cell Sci 125(Pt 10): 2369-80.
26. Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L (2002) EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1(5): 445-57. (Pubitemid 41039125)
27. Selleri C, Montuori N, Ricci P, Visconte V, Carriero MV, et al. (2005) Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood 105: 2198-205. (Pubitemid 40731813)
28. Selleri C, Montuori N, Ricci P, Visconte V, Baiano A, et al. (2006) In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. Cancer Res 66: 10885-90. (Pubitemid 44876986)
29. Mazzieri R, D'Alessio S, Kenmoe RK, Ossowski L, Blasi F (2006) An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration. Mol Biol Cell 17(1): 367-78. (Pubitemid 43049489)
30. Degryse B, Resnati M, Czekay RP, Loskutoff DJ, Blasi F (2005) Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor. J Biol Chem 280: 24792-803. (Pubitemid 40934570)
31. Chaurasia P, Aguirre-Ghiso JA, Liang OD, Gardsvoll H, Ploug M, et al. (2006) A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth. J Biol Chem 281: 14852-63. (Pubitemid 43855190)
32. Huang J, Hu J, Bian X, Chen K, Gong W, et al. (2007) Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells. Cancer Res 67(12): 5906-13. (Pubitemid 46985026)
33. El Zein N, D'Hondt S, Sariban E (2010) Crosstalks between the receptors tyrosine kinase EGFR and TrkA and the GPCR, FPR, in human monocytes are essential for receptors-mediated cell activation. Cell Signal 22(10): 1437-47.
34. Yamada KM, Even-Ram S (2002) Integrin regulation of growth factor receptors. Nat Cell Biol 4: E75-E76. (Pubitemid 34308845)
35. Comoglio PM, Boccaccio C, Trusolino L (2003) Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr Opin Cell Biol 15(5): 565-71. (Pubitemid 37176965)
36. Margadant C, Monsuur HN, Norman JC, Sonnenberg A (2011) Mechanisms of integrin activation and trafficking. Curr Opin Cell Biol 23(5): 607-14.
37. Miettinen HM, Gripentrog JM, Jesaitis AJ (1998) Chemotaxis of chinese hamster ovary cells expressing the human neutrophil formyl peptide receptor: role of signal transduction molecules and alpha5beta1 integrin. J Cell Sci. 111:1921-8. (Pubitemid 28391058)
38. Sadhu C, Masinovsky B, Staunton DE (1998) Differential regulation of chemoattractant-stimulated beta 2, beta 3, and beta 7 integrin activity. J Immunol 160(11):5622-8. (Pubitemid 28267857)
39. Campbell JJ, Qin S, Bacon KB, Mackay CR, Butcher EC. (1996) Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells. J Cell Biol 134(1):255-66. (Pubitemid 26231535)
40. Cunningham O, Andolfo A, Santovito ML, Iuzzolino L, Blasi F, et al. (2003) Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J 22(22): 5994-6003. (Pubitemid 37463243)